Anika Therapeutics (ANIK) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.78 +2.06%
Financial Fact:
Licensing, milestone and contract revenue: 6K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Licensing, milestone and contract revenue: 6K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q4 EPS of $0.54, $0.01 better than the analyst estimate of $0.53. Revenue for the quarter came in at $28.7 million versus the consensus estimate of $27.84 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
- Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
